| Authors: |
Enriquez AS; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Avalos RD; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Parekh D; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA., Cooper CL; International AIDS Vaccine Initiative; New York, NY, 10004, USA., Morrow G; International AIDS Vaccine Initiative; New York, NY, 10004, USA., Geisbert TW; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, 77555, USA., Parks CL; International AIDS Vaccine Initiative; New York, NY, 10004, USA., Hastie KM; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA. Electronic address: kmhastie@lji.org., Saphire EO; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA; Dept. of Medicine, University of California San Diego, La Jolla, CA, 92093, USA. Electronic address: erica@lji.org. |
